William McKee compensation by year
C4 Therapeutics Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $0 | $0 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $1,025,271 | $0 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $1,074,474 | $348,403 |
| Total | $2,099,745 | $348,403 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: C4 Therapeutics, Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-130938, and prior-year filings. Open the filing on EDGAR.
How this page was built: the C4 Therapeutics, Inc. filed document, accession 0001193125-22-130938. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.
C4 Therapeutics’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Lauren White | Chief Financial Officer | $4,085,603 |
| Stewart Fisher | Chief Scientific Officer | $3,788,874 |
| Adam Crystal | Chief Medical Officer | $3,564,503 |
| Jolie Siegel | Chief Legal Officer & Secretary | $3,375,441 |
| Andrew Hirsch | President & Chief Executive Officer | $952,200 |
| William McKee · this page | Former Chief Financial Officer | $348,403 |
The full C4 Therapeutics compensation record
free company briefThis page is one person within C4 Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the C4 Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are C4 Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.